Skip to main content
SpringerLink
Log in

Psychological and Sleep

  • Chapter
  • First Online:
Integrative Geriatric Nutrition

  • 623 Accesses

Abstract

The mental health of the older adult population requires the practitioner to invest time in understanding the life events and lifestyle of their patients in order to adequately assess and support this key area of health. Older adults often find themselves in highly stressful environments. Big life stresses such as the loss of a spouse or loved ones, financial strain, health concerns, polypharmacy, and social isolation are common and can trigger imbalances in mental health. Even in patients with previously well-managed psychological conditions, medications begin to fail, new triggers create a higher need, and additional compromise in health ignites a mental health crisis. Complementing psychotherapy with nutritional improvements, well-placed nutraceuticals, and safe movement such as Tai Chi or swimming addresses the root causes of symptoms. Paying attention to the interconnection between brain health and gut health is critical to addressing the root causes driving the inflammation, toxicity, and hormonal imbalances that lay the foundation for psychological distress. Recognizing the bidirectional information highway between the gut and the brain, the enteric nervous system with the longest nerve in the body called the vagus nerve, is the key to understanding the interconnectedness of the two and, thus, supporting healing in the seat of our psychological state, the brain. The manifestations of various imbalances in the gut, inflammatory responses, and detoxification pathways can manifest as psychological distress. The most common psychological disorders in the aging adult population are depression, anxiety, and insomnia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 2015;28(1):1–6.

    Article  PubMed  Google Scholar 

  2. Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr. 2014;99(1):181–97.

    Article  PubMed  CAS  Google Scholar 

  3. Breit S, Kupferberg A, Rogler G, Hasler G. Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders. Front Psych. 2018;9:44.

    Article  Google Scholar 

  4. Craft LL, Perna FM. The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry. 2004;6(3):104–11.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Blake H. Physical activity and exercise in the treatment of depression. Front Psych. 2012;3:106.

    Google Scholar 

  6. Carvalho AF, Cavalcante JL, Castelo MS, Lima MCO. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther. 2007;32(5):415–28.

    Article  PubMed  CAS  Google Scholar 

  7. Terry N, Margolis KG. Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2016;239:319.

    Article  CAS  Google Scholar 

  8. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–66.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Mawe GM, Hoffman JM. Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Sarris J, O’Neil A, Coulson CE, Schweitzer I, Berk M. Lifestyle medicine for depression. BMC Psychiatry. 2014;14(1):107.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Nikolova V, Zaidi SY, Young AH, Cleare AJ, Stone JM. Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: systematic review and meta-analysis. Ther Adv Psychopharmacol. 2019;9:2045125319859963.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13(2):227–39.

    Article  PubMed  Google Scholar 

  13. Larrieu T, Layé S. Food for mood: relevance of nutritional omega-3 fatty acids for depression and anxiety. Front Physiol. 2018;9:1047.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Schwalfenberg G. Omega-3 fatty acids: their beneficial role in cardiovascular health. Can Fam Physician. 2006;52:734–40.

    PubMed  PubMed Central  Google Scholar 

  15. Swann OG, Kilpatrick M, Breslin M, Oddy WH. Dietary fiber and its associations with depression and inflammation. Nutr Rev. 2020;78(5):394–411.

    Article  PubMed  Google Scholar 

  16. Bliss DZ, Savik K, Jung H-JG, Whitebird R, Lowry A. Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence. Nurs Res. 2011;60(3 Suppl):S58–67.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy–a review. Nutrients. 2016;8(2):68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008;13(3):216–26.

    PubMed  Google Scholar 

  19. Shelton RC, Sloan Manning J, Barrentine LW, Tipa EV. Assessing effects of l-methylfolate in depression management: results of a real-world patient experience trial. Prim Care Companion CNS Disord. 2013;15(4):PCC.13m01520.

    Article  PubMed  PubMed Central  Google Scholar 

  20. NIH. Folate [Internet]. National Institutes of Health Office of Dietary Supplements. 2020 [cited 2020 Dec 30]. Available from: https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/.

  21. Galizia I, Oldani L, Macritchie K, Amari E, Dougall D, Jones TN, et al. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database Syst Rev. 2016;10:CD011286.

    PubMed  Google Scholar 

  22. Górska-Warsewicz H, Laskowski W, Kulykovets O, Kudlińska-Chylak A, Czeczotko M, Rejman K. Food products as sources of protein and amino acids-the case of Poland. Nutrients. 2018;10(12):1977.

    Article  PubMed Central  CAS  Google Scholar 

  23. Berigan TR. A case report of a manic episode triggered by S-Adenosylmethionine (SAMe). Prim Care Companion J Clin Psychiatry. 2002;4(4):159.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999;156(4):646–9.

    Article  PubMed  CAS  Google Scholar 

  25. Bentley C, Hazeldine J, Greig C, Lord J, Foster M. Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient. Burns Trauma. 2019;7:26.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mental Health America. Rhodiola Rosea [Internet]. Mental Health America. 2020 [cited 2021 Mar 3]. Available from: https://www.mhanational.org/rhodiola-rosea

  27. Siddiqui MJ, Saleh MSM, Basharuddin SNBB, Zamri SHB, Mohd Najib MHB, Che Ibrahim MZB, et al. Saffron (Crocus sativus L.): as an antidepressant. J Pharm Bioallied Sci. 2018;10(4):173–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Bostan HB, Mehri S, Hosseinzadeh H. Toxicology effects of saffron and its constituents: a review. Iran J Basic Med Sci. 2017;20(2):110–21.

    PubMed  PubMed Central  Google Scholar 

  29. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92.

    Article  PubMed Central  CAS  Google Scholar 

  30. Gaster B, Holroyd J. St John’s wort for depression: a systematic review. Arch Intern Med. 2000;160(2):152–6.

    Article  PubMed  CAS  Google Scholar 

  31. Butterweck V. Mechanism of action of St John’s wort in depression: what is known? CNS Drugs. 2003;17(8):539–62.

    Article  PubMed  CAS  Google Scholar 

  32. Croke LM. Beers criteria for inappropriate medication use in older patients: an update from the AGS. Am Fam Physician. 2020;101(1):56–7.

    PubMed  Google Scholar 

  33. Jiang H-Y, Zhang X, Yu Z-H, Zhang Z, Deng M, Zhao J-H, et al. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res. 2018;104:130–6.

    Article  PubMed  Google Scholar 

  34. Murphy M, Mercer JG. Diet-regulated anxiety. Int J Endocrinol. 2013;2013:701967.

    Article  PubMed  PubMed Central  Google Scholar 

  35. DeJesus RS, Breitkopf CR, Ebbert JO, Rutten LJF, Jacobson RM, Jacobson DJ, et al. Associations between anxiety disorder diagnoses and body mass index differ by age, sex and race: a population based study. Clin Pract Epidemiol Ment Health. 2016;12:67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Teufel M, Biedermann T, Rapps N, Hausteiner C, Henningsen P, Enck P, et al. Psychological burden of food allergy. World J Gastroenterol. 2007;13(25):3456–65.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Fonseka TM, Müller DJ, Kennedy SH. Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications. Mol Neuropsychiatry. 2016;2(1):1–14.

    PubMed  PubMed Central  Google Scholar 

  38. Naidoo U. This is your brain on food (an Indispensible guide to the surprising foods that fight depression, anxiety, PTSD, OCD, ADHD, and more). 1st ed. Brown Spark: Little; 2020.

    Google Scholar 

  39. Whitbread D. Top 10 Foods Highest in Fiber [Internet]. My Food Data. 2020 [cited 2021 Mar 3]. Available from: https://www.myfooddata.com/articles/foods-high-in-dietary-fiber.php.

  40. Friedman M. Analysis, nutrition, and health benefits of tryptophan. Int J Tryptophan Res. 2018;11:1178646918802282.

    Article  PubMed  PubMed Central  Google Scholar 

  41. NIH. Magnesium [Internet]. National Institutes of Health Office of Dietary Supplements. 2020 [cited 2020 Dec 30]. Available from: https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/#:~:text=Magnesium%20is%20widely%20distributed%20in,cereals%20and%20other%20fortified%20foods.

  42. Young LM, Pipingas A, White DJ, Gauci S, Scholey A. A systematic review and meta-analysis of B vitamin supplementation on depressive symptoms, anxiety, and stress: effects on healthy and “at-risk” individuals. Nutrients. 2019;11(9):2232.

    Article  PubMed Central  CAS  Google Scholar 

  43. Lewis JE, Tiozzo E, Melillo AB, Leonard S, Chen L, Mendez A, et al. The effect of methylated vitamin B complex on depressive and anxiety symptoms and quality of life in adults with depression. ISRN Psychiatry. 2013;2013:621453.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11(10):2362.

    Article  PubMed Central  CAS  Google Scholar 

  45. Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat. 2015;11:165–75.

    PubMed  PubMed Central  Google Scholar 

  46. Ngo D-H, Vo TS. An updated review on pharmaceutical properties of gamma-aminobutyric acid. Molecules. 2019;24(15):2678.

    Article  PubMed Central  CAS  Google Scholar 

  47. Shimada M, Hasegawa T, Nishimura C, Kan H, Kanno T, Nakamura T, et al. Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. Clin Exp Hypertens. 2009;31(4):342–54.

    Article  PubMed  CAS  Google Scholar 

  48. Kofman O, Einat H, Cohen H, Tenne H, Shoshana C. The anxiolytic effect of chronic inositol depends on the baseline level of anxiety. J Neural Transm. 2000;107(2):241–53.

    Article  PubMed  CAS  Google Scholar 

  49. Zheng X, Liu Z, Zhang Y, Lin Y, Song J, Zheng L, et al. Relationship between Myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis. Medicine (Baltimore). 2015;94(42):e1604.

    Article  CAS  Google Scholar 

  50. Malcolm BJ, Tallian K. Essential oil of lavender in anxiety disorders: ready for prime time? Ment Health Clin. 2017;7(4):147–55.

    Article  PubMed  Google Scholar 

  51. Appel K, Rose T, Fiebich B, Kammler T, Hoffmann C, Weiss G. Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2011;25(6):838–43.

    Article  PubMed  CAS  Google Scholar 

  52. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363–7.

    Article  PubMed  CAS  Google Scholar 

  53. Srivastava JK, Shankar E, Gupta S. Chamomile: a herbal medicine of the past with bright future. Mol Med Report. 2010;3(6):895–901.

    PubMed Central  CAS  Google Scholar 

  54. Mao JJ, Li QS, Soeller I, Rockwell K, Xie SX, Amsterdam JD. Long-term chamomile therapy of generalized anxiety disorder: a study protocol for a randomized, double-blind, placebo- controlled trial. J Clin Trials. 2014;4(5):188.

    PubMed  PubMed Central  Google Scholar 

  55. Mao JJ, Li QS, Soeller I, Xie SX, Amsterdam JD. Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial. J Clin Trials. 2014;4:170.

    PubMed  PubMed Central  Google Scholar 

  56. Meissner H, Cascella M. Cannabidiol (CBD) [Internet]. PubMed. 2021 [cited 2021 Mar 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556048/.

  57. Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 2002;16(11):731–43.

    Article  PubMed  Google Scholar 

  58. Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res. 2004;18(4):297–300.

    Article  PubMed  CAS  Google Scholar 

  59. Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 2000;20(1):84–9.

    Article  PubMed  CAS  Google Scholar 

  60. Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010;17(6):397–403.

    Article  PubMed  CAS  Google Scholar 

  61. Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutr Metab. 2011;4(3):211–8.

    Article  Google Scholar 

  62. Büchner KH, Hellings H, Huber M, Peukert E, Späth L, Deininger R. Double blind study as evidence of the therapeutic effect of Melissengeist on psycho-vegetative syndromes (author’s transl). Med Klin. 1974;69(23):1032–6.

    PubMed  Google Scholar 

  63. Patel D, Steinberg J, Patel P. Insomnia in the elderly: a review. J Clin Sleep Med. 2018;14(6):1017–24.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Curtis AF, Williams JM, McCoy KJM, McCrae CS. Chronic pain, sleep, and cognition in older adults with insomnia: a daily multilevel analysis. J Clin Sleep Med. 2018;14(10):1765–72.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Miner B, Kryger MH. Sleep in the aging population. Sleep Med Clin. 2017;12(1):31–8.

    Article  PubMed  Google Scholar 

  66. Rumble R, Morgan K. Hypnotics, sleep, and mortality in elderly people. J Am Geriatr Soc. 1992;40(8):787–91.

    Article  PubMed  CAS  Google Scholar 

  67. Morgan K. Hypnotics in the elderly. What cause for concern? Drugs. 1990;40(5):688–96.

    Article  PubMed  CAS  Google Scholar 

  68. Chen L, Bell JS, Visvanathan R, Hilmer SN, Emery T, Robson L, et al. The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study. BMC Geriatr. 2016;16(1):196.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Airagnes G, Pelissolo A, Lavallée M, Flament M, Limosin F. Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep. 2016;18(10):89.

    Article  PubMed  Google Scholar 

  70. Edwards BA, O’Driscoll DM, Ali A, Jordan AS, Trinder J, Malhotra A. Aging and sleep: physiology and pathophysiology. Semin Respir Crit Care Med. 2010;31(5):618–33.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Sloane PD, Figueiro M, Cohen L. Light as therapy for sleep disorders and depression in older adults. Clin Geriatr. 2008;16(3):25–31.

    PubMed  PubMed Central  Google Scholar 

  72. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6(4):1501–18.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. van Ballegooijen AJ, Cepelis A, Visser M, Brouwer IA, van Schoor NM, Beulens JW. Joint association of low vitamin D and vitamin K status with blood pressure and hypertension. Hypertension. 2017;69(6):1165–72.

    Article  PubMed  CAS  Google Scholar 

  74. Okereke OI, Singh A. The role of vitamin D in the prevention of late-life depression. J Affect Disord. 2016;198:1–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q. The association between vitamin D deficiency and sleep disorders: a systematic review and meta-analysis. Nutrients. 2018;10(10):1395.

    Article  PubMed Central  CAS  Google Scholar 

  76. Bičíková M, Dušková M, Vítků J, Kalvachová B, Řípová D, Mohr P, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl 2):S101–3.

    Article  PubMed  Google Scholar 

  77. Gehrman P, Shah MT, Miles A, Kuna S, Godleski L. Feasibility of group cognitive-behavioral treatment of insomnia delivered by clinical video telehealth. Telemed J E Health. 2016;22(12):1041–6.

    Article  PubMed  Google Scholar 

  78. Whitehurst LN, Fogler K, Hall K, Hartmann M, Dyche J. The effects of chronic marijuana use on circadian entrainment. Chronobiol Int. 2015;32(4):561–7.

    Article  PubMed  Google Scholar 

  79. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, et al. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci. 2009;119(6):821–46.

    Article  PubMed  CAS  Google Scholar 

  81. Djokic G, Vojvodić P, Korcok D, Agic A, Rankovic A, Djordjevic V, et al. The effects of magnesium – melatonin – Vit B complex supplementation in treatment of insomnia. Open Access Maced J Med Sci. 2019;7(18):3101–5.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Kim S, Jo K, Hong K-B, Han SH, Suh HJ. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep. Pharm Biol. 2019;57(1):65–73.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Byun JI, Shin YY, Chung SE, Shin WC. Safety and efficacy of gamma-aminobutyric acid from fermented rice germ in patients with insomnia symptoms: a randomized, Double-Blind Trial. J Clin Neurol. 2018;14(3):291–5.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Rancillac A. Serotonin and sleep-promoting neurons. Oncotarget. 2016;7(48):78222–3.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Hinz M, Stein A, Uncini T. 5-HTP efficacy and contraindications. Neuropsychiatr Dis Treat. 2012;8:323–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  86. Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22–7.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Schneider-Helmert D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology. 1986;89(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  88. Cunha JP. Chamomile [Internet]. RxList. 2021 [cited 2021 Mar 3]. Available from: https://www.rxlist.com/consumer_chamomile/drugs-condition.htm.

  89. Healthline. 10 Benefits of Lemon Balm and How to Use It [Internet]. Healthline. 2017 [cited 2021 Mar 4]. Available from: https://www.healthline.com/health/lemon-balm-uses.

  90. Cunha JP. Kava [Internet]. RxList. 2017 [cited 2021 Mar 4]. Available from: https://www.rxlist.com/consumer_kava/drugs-condition.htm.

  91. Cunha JP. Passion Flower [Internet]. RxList. 2021 [cited 2021 Mar 3]. Available from: https://www.rxlist.com/consumer_passion_flower/drugs-condition.htm.

  92. Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G. Effectiveness of valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2010;11(6):505–11.

    Article  PubMed  Google Scholar 

  93. Bent S, Padula A, Moore D, Patterson M, Mehling W. Valerian for sleep: a systematic review and meta-analysis. Am J Med. 2006;119(12):1005–12.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Franco L, Sánchez C, Bravo R, Rodriguez A, Barriga C, Juánez JC. The sedative effects of hops (Humulus lupulus), a component of beer, on the activity/rest rhythm. Acta Physiol Hung. 2012;99(2):133–9.

    Article  PubMed  CAS  Google Scholar 

  95. Hops. LiverTox: clinical and research information on drug-induced liver injury. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2012.

    Google Scholar 

  96. Doherty R, Madigan S, Warrington G, Ellis J. Sleep and nutrition interactions: implications for athletes. Nutrients. 2019;11(4):822.

    Article  PubMed Central  CAS  Google Scholar 

  97. Madzima TA, Melanson JT, Black JR, Nepocatych S. Pre-sleep consumption of casein and whey protein: effects on morning metabolism and resistance exercise performance in active women. Nutrients. 2018;10(9):1273.

    Article  PubMed Central  CAS  Google Scholar 

  98. Vasconcelos QDJS, Bachur TPR, Aragão GF. Whey protein supplementation and its potentially adverse effects on health: a systematic review. Appl Physiol Nutr Metab. 2021;46(1):27–33.

    Article  PubMed  Google Scholar 

  99. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74(4):580–91.

    Article  PubMed  Google Scholar 

  100. Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the “SMILES” trial). BMC Med. 2017;15(1):23.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Huang Q, Liu H, Suzuki K, Ma S, Liu C. Linking what we eat to our mood: a review of diet, dietary antioxidants, and depression. Antioxidants (Basel). 2019;8(9):376.

    Article  CAS  Google Scholar 

  102. Bressan P, Kramer P. Bread and other edible agents of mental disease. Front Hum Neurosci. 2016;10:130.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  103. Hussin NM, Shahar S, Teng NIMF, Ngah WZW, Das SK. Efficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men. J Nutr Health Aging. 2013;17(8):674–80.

    Article  PubMed  CAS  Google Scholar 

  104. Redman LM, Martin CK, Williamson DA, Ravussin E. Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes. Physiol Behav. 2008;94(5):643–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Michalsen A, Weidenhammer W, Melchart D, Langhorst J, Saha J, Dobos G. Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes–well-being and side effects with and without mineral supplements. Forsch Komplementarmed Klass Naturheilkd. 2002;9(4):221–7.

    PubMed  CAS  Google Scholar 

  106. Zhang Y, Liu C, Zhao Y, Zhang X, Li B, Cui R. The effects of calorie restriction in depression and potential mechanisms. Curr Neuropharmacol. 2015;13(4):536–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Bozzatello P, Brignolo E, De Grandi E, Bellino S. Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data. J Clin Med. 2016;5(8):67.

    Article  PubMed Central  CAS  Google Scholar 

  108. NIH. Omega-3 Fatty Acids [Internet]. NIH Office of Dietary Supplements. 2020 [cited 2021 Mar 4]. Available from: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/.

  109. Olson CR, Mello CV. Significance of vitamin a to brain function, behavior and learning. Mol Nutr Food Res. 2010;54(4):489–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  110. NIH. Vitamin A [Internet]. Vitamin A. 2020 [cited 2021 Jan 30]. Available from: https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/.

  111. Kubala J. Vitamin A: benefits, deficiency, toxicity and more [Internet]. Healthline. 2018 [cited 2021 Mar 4]. Available from: https://www.healthline.com/nutrition/vitamin-a.

  112. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. George Washington University School of Medicine and Health Sciences, Washington, DC, USA

    Julie Wendt

  2. George Washington University, Washington, DC, USA

    Colleen Considine

  3. GW Center for Integrative Medicine, George Washington University, Washington, DC, USA

    Mikhail Kogan

Authors
  1. Julie Wendt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colleen Considine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikhail Kogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Wendt .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wendt, J., Considine, C., Kogan, M. (2021). Psychological and Sleep. In: Integrative Geriatric Nutrition. Springer, Cham. https://doi.org/10.1007/978-3-030-81758-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81758-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81757-2

  • Online ISBN: 978-3-030-81758-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation